|
|
|
|
There is a striking absence of evidence about pharmacological treatment of cognitive impairment and dementia in people older than 40 years with Down?s syndrome. Despite promising indications, memantine is not an effective treatment. Therapies that are effective for Alzheimer?s disease are not necessarily effective in this group of patients. |
|